NASDAQ: QNTM
Quantum Biopharma Ltd Stock Ownership - Who owns Quantum Biopharma?

Insider buying vs selling

Have Quantum Biopharma Ltd insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when QNTM insiders and whales buy or sell their stock.

QNTM Shareholders

What type of owners hold Quantum Biopharma Ltd stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Advisorshares Investments LLC1.81%48,990$1.10MInstitution
Jw Cole Advisors Inc0.46%12,590$283.40kInstitution
Tower Research Capital LLC Trc0.12%3,195$71.92kInstitution
Morgan Stanley0.09%2,532$57.00kInstitution
Ubs Group Ag0.06%1,614$36.33kInstitution
Thompson Investment Management Inc0.01%325$7.32kInstitution
Cetera Trust Company Na0.01%250$5.63kInstitution
Sbi Securities Co Ltd0.01%157$3.53kInstitution
Group One Trading LLC0.00%115$2.59kInstitution
National Bank Of Canada0.00%92$2.07kInstitution

1 of 2

QNTM vs Pharmaceutical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
QNTM2.58%0.00%
ASRT26.52%21.34%Net SellingNet Selling
CPIX28.61%55.81%Net BuyingNet Buying
BGM1.30%0.00%
INCR5.27%0.00%

Quantum Biopharma Stock Ownership FAQ

Who owns Quantum Biopharma?

Quantum Biopharma (NASDAQ: QNTM) is owned by 2.58% institutional shareholders, 0.00% Quantum Biopharma insiders, and 97.42% retail investors. Advisorshares Investments LLC is the largest individual Quantum Biopharma shareholder, owning 48,990.00 shares representing 1.81% of the company. Advisorshares Investments LLC's Quantum Biopharma shares are currently valued at $1.10M.

If you're new to stock investing, here's how to buy Quantum Biopharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.